ReviewEndocrinology and metabolism clinics of North America2021
Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.
Review in Endocrinology and metabolism clinics of North America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- The regulation of intrahepatic fatty acid partitioning within the human liver: the effect of sex.Clinical science (London, England : 1979) · 2026Review
- Steroid Cell Tumor of the Ovary Presenting With Postmenopausal Bleeding and Hyperandrogenism: A Case Report.Cureus · 2026Article
- Androgen-Secreting Adrenal Adenoma in a Postmenopausal Woman as a Cause of Hirsutism.JCEM case reports · 2025Article
- Article
- Case Report: Postmenopausal hyperandrogenism misled by adrenal incidentaloma: a rare case of androgen-secreting ovarian adult granulosa cell tumor and clinical implications.Frontiers in oncology · 2025Article
- Endogenous androgens, coronary atheroma and remodeling in women with suspected ischemic heart disease: A report from the Women's Ischemia Syndrome Evaluation (WISE) study.American heart journal plus : cardiology research and practice · 2024Article
- Leydig tumor in normal sized ovaries causing clitoromegaly: A case report.Gynecologic oncology reports · 2024Article
- Aging and Adiposity-Focus on Biological Females at Midlife and Beyond.International journal of molecular sciences · 2024Review
- Article
- The value of ovarian hyperstimulation syndrome in predicting pregnancy outcome in women with polycystic ovarian syndrome and candidate for in vitro fertilization: A case-control study.International journal of reproductive biomedicine · 2023Article
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications.JCEM case reports · 2023Article
- Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.Medicina (Kaunas, Lithuania) · 2023Review
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.The Journal of clinical endocrinology and metabolism · 2023Review
- Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism.SAGE open medical case reports · 2023Article
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden.Biomedicines · 2022Article
- The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.International journal of molecular sciences · 2022Review
- Association between testosterone levels and bone mineral density in females aged 40-60 years from NHANES 2011-2016.Scientific reports · 2022Article
- Hirsutism, Male Pattern Baldness, and Acne in a 60-Year-Old Woman.AACE endocrinology and diabetesArticle
- Ovarian Hyperthecosis Presenting as Polycythemia.AACE clinical case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Evidence of clinical and/or biochemical androgen excess poses a unique differential in postmenopausal women. Some signs and symptoms of postmenopausal hyperandrogenism can be normal and attributed to the natural aging process. However, the causes of androgen excess in this group include both nontumorous and tumorous causes. Treatment of androgen excess may improve both quality of life and long-term metabolic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.